UNIVERSITY OF LIVERPOOL IMAGE: MOLECULAR MODELLING OF INTERACTIONS OF HEPARIN SACCHARIDES (COLOURED STICK AND BALLS) WITH THE RECEPTOR BINDING DOMAIN OF THE SPIKE PROTEIN OF SARS-COV2 VIRUS (YELLOW/GREEN RIBBON), WHICH INTERFERE WITH ITS BINDING TO THE ACE2 RECEPTOR OF HUMAN CELLS. CREDIT: MYCROFT-WEST ET AL. An international team of researchers led by the Universities of Liverpool and...
by Mary L. Martialay, Rensselaer Polytechnic Institute In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease. Heparin, a common blood thinner, and a heparin variant stripped of its anticoagulant properties, performed on par with remdesivir...
Key facts: Millions are already taking tablets containing heparin to reduce the risk of clots The new patch automatically injects the same drug through miniature needles This prevents patients from taking too much, which can cause fatal bleeding A high-tech skin patch could prevent deadly blood clots that cause strokes and heart attacks. The patch...
